- Home
- SYBX vs EQS Comparison
SYBX vs EQS Comparison
Compare SYBX & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- EQS
- Stock Information
- Founded
- SYBX N/A
- EQS 1991
- Country
- SYBX United States
- EQS United States
- Employees
- SYBX N/A
- EQS N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- SYBX Health Care
- EQS Finance
- Exchange
- SYBX Nasdaq
- EQS Nasdaq
- Market Cap
- SYBX 11.8M
- EQS 13.9M
- IPO Year
- SYBX N/A
- EQS N/A
- Fundamental
- Price
- SYBX $1.16
- EQS $1.00
- Analyst Decision
- SYBX
- EQS
- Analyst Count
- SYBX 0
- EQS 0
- Target Price
- SYBX N/A
- EQS N/A
- AVG Volume (30 Days)
- SYBX 13.5K
- EQS 4.5K
- Earning Date
- SYBX 05-13-2025
- EQS 01-01-0001
- Dividend Yield
- SYBX N/A
- EQS N/A
- EPS Growth
- SYBX N/A
- EQS N/A
- EPS
- SYBX N/A
- EQS N/A
- Revenue
- SYBX $8,000.00
- EQS $1,274,000.00
- Revenue This Year
- SYBX N/A
- EQS N/A
- Revenue Next Year
- SYBX N/A
- EQS N/A
- P/E Ratio
- SYBX N/A
- EQS N/A
- Revenue Growth
- SYBX N/A
- EQS 411.65
- 52 Week Low
- SYBX $0.90
- EQS $0.87
- 52 Week High
- SYBX $1.96
- EQS $1.53
- Technical
- Relative Strength Index (RSI)
- SYBX 50.18
- EQS 45.90
- Support Level
- SYBX $1.00
- EQS $0.93
- Resistance Level
- SYBX $1.10
- EQS $1.06
- Average True Range (ATR)
- SYBX 0.10
- EQS 0.05
- MACD
- SYBX 0.01
- EQS 0.01
- Stochastic Oscillator
- SYBX 84.64
- EQS 68.42
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.